Uptake of amiodarone by thyroidal and non-thyroidal cell lines

Journal of Endocrinological Investigation

Volumn 29, Issue 1, 2006, Pages 61-66

  Bogazzi, F ^a   Raggi, F ^a   Ultimieri, F ^a   Russo, D ^a   Cosci, C ^a   Cecchetti, P ^a   Dell'Unto, E ^a   Sardella, C ^a   Tonacchera, M ^a   Vitti, P ^a   Benzi, L ^a   Bartalena, L ^b   Martino, E ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

Amiodarone; Desethylamiodarone; NIS; Thyroid

Indexed keywords

AMIODARONE; DEETHYLAMIODARONE; IODINE 125; POTASSIUM PERCHLORATE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL LINE; CELL VIABILITY; CHO CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOTOXICITY; DRUG EXPOSURE; DRUG UPTAKE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NONHUMAN; THYROID CELL;

EID: 33644830262     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03349178     Document Type: Article

References (29)

1. Martino E, Bartalena L, Bogazzi F, Braverman LE. The effects of amiodarone on thyroid. Endocr Rev 2001, 22: 240-54.
2. Brien JF, Jummo S, Brennan FJ, Ford SE, Armstrong PW. Distribution of amiodarone and its metabolite, desethylamiodarone, in human tissues. Can J Physiol Pharmacol 1987,65:360-4.
3. Amico JA, Richardson V, Albert B, Klein I. Clinical and chemical assesment of thyroid function during therapy with amiodarone. Arch Intern Med 1984,144:487-90.
4. Sanmarti A, Permaneyer-Miralda G, Castellanos JM, FosSala M, Galard RM, Soler-Soler J. Chronic administration of amiodarone and thyroid function: a foloow-up study. Am Heart J 1984,108:1262-8.
5. Trip MD, Wiersinga WM, Plomp TA. Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism. Am J Med 1991, 91: 507-11.
6. Kannan R, Ookhtens M, Chopra IJ. Effects of chronic administration of amiodarone of kinetics of metabolism of iodothyronines. Endocrinology 1984,115:1710-6.
7. Sogol PM, Hersharn JM, Reed AW, Dilmann WH. The effects of amiodarone on serum thyroid hormones and hepatuic thyroxine 5′-monodeiodination in rats. Endocrinology 1983,113:1464-9.
8. Norman MF, Lavin TN. Antagonism of thyroid hormone action by amiodarone in rat pituitary tumor cells, J Clin Invest 1989,83:306-13.
9. Rani CS. Amiodarone effects on thyrotropin receptors and responses stimulated by thyrotropin and carbachol in cultureted dog thyroid cells. Endocrinology 1990, 127: 2930-7.
10. Disatnik MH, Shainberg A. Regulation of beta-adrenoceptors by thyroid hormone and amiodarone in rat myocardic cells in culture. Biochem Pharmacol 1991, 22:1039-44.
11. 3 on beta adrenergic receptor density in rat heart. Horm Metab Res 1990,22:85-9.
12. Wartofsky L, Burman HD. Alterations in thyroid function in patients with systemic illness the "euthyroid sick syndrome". Endocr Rev 1982,3:164-217.
13. Bagchi N, Brown TR, Schneider DS, Benerjee SK. Effect of amiodarone on the rat heart myosin isoenzymes. Circ Res 1987, 60: 621-5.
14. Bakker 0, Hudig F, Meijssen S, Wiersinga WM. Effects of triiodothyronine and amiodarone on the promoter of the human LDL receptor gene. Biochem Biophys Res Commun 1998,249:517-21.
15. van Beeren HC, Bakker 0, Wiersinga WM. Structure-function relationship of the inhibition of the 3,5,3′-triiodothyronine binding to the alphal-and beta 1-thyroid hormone receptor by amiodarone analogs. Endocrinology 1996,137: 2807-14.
16. Bogazzi F, Bartalena L, Gasperi M, Braverman LE, Martino E. The various effects of amiodarone on thyroid function. Thyroid 2001, 11: 511-9.
17. Chiovato L, Martino E, Tonacchera M, et al. Studies on the in vitro cytotoxic effect of amiodarone. Endocrinology 1994, 134:2277-82.
18. Vitale M, Di Matola T, D'Ascoli F, et al. Iodide excess induces apoptosis in thyroid cells through a p53-independent mechanism involving oxidative stress. Endocrinology 2000, 141:598-605.
19. Di Matola T, D'Ascoli F, Fenzi G, et al. Amiodarone induces cytochrome c release and apoptosis through an iodine-independent mechanism. J Clin Endocrinol Metab 2000,85:4323-30.
20. Tonacchera M, Agretti P, Ceccarini G, et al. Autoantibodies from patients with autoimmune thyroid disease do not interfere with the activity of the human iodide symporter gene stably transfected in CHO cells. Eur J Endocrinol 2001,144:611-8.
21. Plomp TA, Engels M, Robles de Medina EO, Maes RA. Simultaneous determination of amiodarone and its major metabolite desethylamiodarone in plasma, urin and tissues by high-performance liquid chromatography. J Chromatogr 1983,273: 379-92.
22. Meese R, Smitherman TC, Croft CH, Burger A, Nicod P. Effect of peripheral thyroid hormone metabolism on cardiac arrhythmias. Am J Cardiol 1985,55: 849-51.
23. Hudig F, Bakker 0, Wiersinga WM. Amiodarone decreases gene expression of low-density lipoprotein receptorat both the m RNA and the protein level. Metabolism 1998,47:1052-7.
24. Franklyn JA, Gammage MD, Sheppard MC. Amiodarone and thyroid hormone effects on anterior pituitary hormone gene expression. Clin Endocrinol (Oxf) 1987,27:373-82.
25. Paradis P, Lambert C, Rouleau J. Amiodarone antagonizes the effect of T3 at the receptor level: an additional mechanism for its in vivo hypothyroid-like effects. Can J Physiol Pharmacol 1991, 69: 865-70.
26. Latham KR, Sellitti DF, Goldstein RE. Interaction of amiodarone and desethylamiodarone with solubilized nuclear thyroid hormone receptors. J Am Coll Cardiol 1987,9:872-6.
27. Bakker 0, van Beeren HC, Wiersinga WM. Desethylamiodarone is a noncompetitive inhibitor of the binding of thyroid hormone to the thyroid hormone β1 -receptor protein. Endocrinology 1994,134:1665-70.
28. Honegger UE, Zuehlke RD, Scuntaro I, Schaefer MHA, Toplak H, Wiesmann UN. Cellular accumulation of amiodarone and desethylamiodarone in cultured human cells. Biochem Pharmacol 1993, 45: 349-56.
29. Antonini JM, Reasor MJ. Accumulation of amiodarone and desethylamiodarone by rat alveolar macrophages in cell culture. Biochem Pharmacol 1991,42:151-6.